SPRI | Early Phase Cancer Immunotherapy (2018 EN)

Discussion in 'Medicine' started by Kanka, Nov 14, 2017.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,037
    Likes Received:
    449
    Trophy Points:
    83
    [​IMG]

    Author: Sandip Pravin Patel (Editor), Razelle Kurzrock (Editor)
    Full Title: Early Phase Cancer Immunotherapy
    Publisher: Springer; 1st ed. 2018 edition (November 4, 2017)
    Year: 2018
    ISBN-13: 9783319637570 (978-3-319-63757-0), 9783319637563 (978-3-319-63756-3)
    ISBN-10: 3319637576, 3319637568
    Pages: 331
    Language: English
    Genre: Biomedical Sciences: Cancer Research
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 181.89 €


    This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.

    -------------
     
    Last edited by a moderator: Dec 5, 2019